Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Appoints Christina Coughlin as head of research and development. Coughlin, who will take.
A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to. | April 25, 2023
Oncology-focussed drugs and diagnostics developer Avacta reported full-year revenue of £9.7m in its preliminary results on Tuesday, up from £2.9m year-on-year.
Toronto, ON (PRWEB) July 28, 2022 Natural killer (NK) cells have moved front and center as one of the most exciting therapeutic technologies in clinical
College Station (PRWEB) May 18, 2022 G-CON, the leader in prefabricated, flexible cleanroom solutions, recently supplied the cleanroom infrastructure for